IL16 and cancer: Additionally, IL-16 has been associated with poor prognosis in cancers such as gastric cancer, possibly due to its ability to attract other immune cells into the tumor microenvironment, including regulatory T cells, influencing tumor growth and progression (Liu et al., 2016; Xiong et al., 2022).